Skip to content

    Sargramostim Solution

    conditions

    What conditions does Sargramostim Solution treat?

    Decrease in Neutrophils caused by Leukemia Treatment, Bone Marrow Graft Acceptance, Delay or Failure of Allogenic Bone Marrow Transplant, Myeloid Engraftment Enhancement after Peripheral Blood Progenitor Cell Transplant, Peripheral Blood Stem Cell Therapy, Delay or Failure of Autologous Bone Marrow Transplant

    sargramostim Solution may also be used to treat:

    Bone Marrow Disorders Occurring Before Leukemia, Decrease in White Blood Cells from AIDS, Severe Chronic Decrease of Neutrophils in the Blood, Neutrophils Decreased by Medication

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

    More about Drugs and Medications

    URAC Seal TRUSTe Privacy Certification TAG Registered Seal HONcode Seal AdChoices